Pressure-controlled volume-guaranteed ventilation improved diaphragmatic function and reduced weakness in diabetic patients undergoing laparoscopic colorectal surgery.
This randomized controlled trial evaluated the effects of pressure-controlled volume-guaranteed ventilation (PCV-VG) versus volume-controlled ventilation (VCV) in a cohort of 80 patients diagnosed with Type 2 diabetes undergoing elective laparoscopic colorectal surgery. The primary outcomes focused on diaphragmatic function, assessed via diaphragm thickening fraction (DTF) and diaphragm excursion (DE), while secondary outcomes included intraoperative mechanical power, postoperative pulmonary complications (PPCs), and other complications within the first two days post-surgery.
Results indicated that the PCV-VG group demonstrated significantly lower intraoperative mechanical power compared to the VCV group, with a p-value of 0.002. Furthermore, diaphragm excursion and thickening fraction were significantly improved in the PCV-VG group during the initial two postoperative days. The incidence of postoperative diaphragmatic weakness was also less frequent in the PCV-VG group (p = 0.019). However, no statistically significant difference was found in the incidence of PPCs between the two ventilation strategies (p = 0.155).
Safety data regarding adverse events, serious adverse events, discontinuations, and tolerability were not reported in the study. The authors note that although improvements in diaphragmatic function were observed, these physiological benefits did not translate into a reduction in the clinical incidence of PPCs. This suggests that while PCV-VG may optimize diaphragm mechanics, its broader clinical utility in preventing pulmonary complications in this specific population remains uncertain based on these findings.